{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:07:22Z","timestamp":1761516442021,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.4158\/ep151035.co","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T16:55:28Z","timestamp":1448297728000},"page":"114-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Commentary On \u201cStudy Of The Prevalence Of Autoimmune Thyroid Disease In Women With Breast Cancer\u201d"],"prefix":"10.1016","volume":"22","author":[{"given":"Giovanni","family":"Sisti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariarosaria","family":"Di Tommaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP151035.CO_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4158\/EP14445.OR","article-title":"Study of the prevalence of autoimmune thyroid disease in women with breast cancer","volume":"22","author":"Freitas","year":"2016","journal-title":"Endocr Pract"},{"key":"10.4158\/EP151035.CO_bb0015","first-page":"160","article-title":"Endocrine abnormalities in women with brest cancer","volume":"4","author":"Sommers","year":"1955","journal-title":"Lab Invest"},{"key":"10.4158\/EP151035.CO_bb0020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000227093","article-title":"Benign thyroid diseases and the risk of death from breast cancer","volume":"49","author":"Goldman","year":"1992","journal-title":"Oncology"},{"key":"10.4158\/EP151035.CO_bb0025","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ije\/28.5.816","article-title":"Breast cancer risk in young women and history of selected medical conditions","volume":"28","author":"Weiss","year":"1999","journal-title":"Int J Epidemiol"},{"key":"10.4158\/EP151035.CO_bb0030","first-page":"133","article-title":"Thyroid gland function on breast neoplasm [in Japanese]","volume":"23","author":"Abe","year":"1975","journal-title":"Horumon To Rinsho"},{"key":"10.4158\/EP151035.CO_bb0035","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1097-0142(197802)41:2<666::AID-CNCR2820410234>3.0.CO;2-H","article-title":"Plasma thyroid-stimulating hormone and thyroxine concentrations in breast cancer","volume":"41","author":"Rose","year":"1978","journal-title":"Cancer"},{"key":"10.4158\/EP151035.CO_bb0040","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/1097-0142(197904)43:4<1434::AID-CNCR2820430433>3.0.CO;2-S","article-title":"Plasma triiodothyronine concentrations in breast cancer","volume":"43","author":"Rose DP Davis","year":"1979","journal-title":"Cancer"},{"key":"10.4158\/EP151035.CO_bb0045","first-page":"990","article-title":"Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy","volume":"81","author":"Giani","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP151035.CO_bb0050","first-page":"504","article-title":"Thyroid disorders and breast cancer","volume":"5","author":"Shering","year":"1996","journal-title":"Eur J Cancer Prev"},{"key":"10.4158\/EP151035.CO_bb0055","first-page":"2711","article-title":"Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma","volume":"83","author":"Smyth","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP151035.CO_bb0060","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/1097-0142(196409)17:9<1170::AID-CNCR2820170912>3.0.CO;2-R","article-title":"The relationship of breast disease to thyroid disease","volume":"17","author":"Humphrey","year":"1964","journal-title":"Cancer"},{"key":"10.4158\/EP151035.CO_bb0065","first-page":"263","article-title":"Hashimoto's thyroiditis and breast cancer","volume":"51","author":"Maruchi","year":"1976","journal-title":"Mayo Clin Proc"},{"key":"10.4158\/EP151035.CO_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.1.6004.257","article-title":"Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer","volume":"1","author":"Mittra","year":"1976","journal-title":"Br Med J"},{"key":"10.4158\/EP151035.CO_bb0075","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0021-9681(84)90062-6","article-title":"Relationship of thyroid disease and use of thyroid supplements to breast cancer risk","volume":"37","author":"Brinton","year":"1984","journal-title":"J Chronic Dis"},{"key":"10.4158\/EP151035.CO_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14310\/horm.2002.1152","article-title":"Lack of association between Hashimoto thyroiditis and breast cancer: a quantitative research synthesis","volume":"1","author":"Sarlis","year":"2002","journal-title":"Hormones (Athens)"},{"key":"10.4158\/EP151035.CO_bb0085","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10549-012-2019-3","article-title":"Benign thyroid disease is associated with breast cancer: a meta-analysis","volume":"133","author":"Hardefeldt","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.4158\/EP151035.CO_bb0090","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1089\/thy.2012.0568","article-title":"Cancer risk in patients with Graves' disease: a nationwide cohort study","volume":"23","author":"Chen","year":"2013","journal-title":"Thyroid"},{"key":"10.4158\/EP151035.CO_bb0095","first-page":"1713","article-title":"Thyroid function in breast cancer patients","volume":"30","author":"Ditsch","year":"2010","journal-title":"Anticancer Res"},{"key":"10.4158\/EP151035.CO_bb0100","doi-asserted-by":"crossref","first-page":"10999","DOI":"10.7314\/APJCP.2014.15.24.10999","article-title":"Thyroid autoantibodies and breast cancer","volume":"15","author":"Prinzi","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.4158\/EP151035.CO_bb0105","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.7314\/APJCP.2014.15.16.6643","article-title":"Relationship between breast cancer and levels of serum thyroid hormones and antibodies: a meta-analysis","volume":"15","author":"Shi","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.4158\/EP151035.CO_bb0110","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/BF03350810","article-title":"Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer","volume":"30","author":"Fiore","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP151035.CO_bb0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3892\/mco.2015.521","article-title":"Antithyroid peroxidase antibody positivity is associated with lower incidence of metastasis in breast cancer","volume":"3","author":"Kemal","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.4158\/EP151035.CO_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jso.20071","article-title":"The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women","volume":"87","author":"Cengiz","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.4158\/EP151035.CO_bb0125","first-page":"1603","article-title":"Thyroid autoimmunity occurs more frequently in women with breast cancer compared to women with colorectal cancer and controls but it has no impact on relapse-free and overall survival","volume":"18","author":"Jiskra","year":"2007","journal-title":"Oncol Rep"},{"key":"10.4158\/EP151035.CO_bb0130","first-page":"11","article-title":"Antithyroid antibody levels in patients with breast cancer","volume":"1","author":"D\u00fclger","year":"2004","journal-title":"Eur J Gen Med"},{"key":"10.4158\/EP151035.CO_bb0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF03347458","article-title":"High prevalence of breast cancer in patients with benign thyroid diseases","volume":"34","author":"Muller","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP151035.CO_bb0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/er.2001-0029","article-title":"The sodium\/iodide symporter (NIS): characterization, regulation, and medical significance","volume":"24","author":"Doh\u00e1n","year":"2003","journal-title":"Endocr Rev"},{"key":"10.4158\/EP151035.CO_bb0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/EJE-08-0505","article-title":"Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers","volume":"160","author":"Peyrottes","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP151035.CO_bb0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0960-0760(96)00117-3","article-title":"Triiodothyronine mimics the effects of estrogen in breast cancer cell lines","volume":"59","author":"Nogueira","year":"1996","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20360018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20360018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:02:20Z","timestamp":1761516140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20360018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1530891X20360018"],"URL":"https:\/\/doi.org\/10.4158\/ep151035.co","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Commentary On \u201cStudy Of The Prevalence Of Autoimmune Thyroid Disease In Women With Breast Cancer\u201d","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP151035.CO","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}